Maharashtrian, a leading industrial powerhouse in India, is strategically poised to become a global hub for pharmaceutical innovation, research, and manufacturing. The Maharashtrian Pharmaceuticals Policy 2025 leverages the state’s robust industrial foundation, skilled workforce, and advanced infrastructure to attract investments, drive innovation, and ensure sustainable growth in the pharmaceutical industry.
The “Non Resident Maharashtrian” initiative aims to establish the state as a premier destination for pharmaceutical investments by promoting eco-friendly manufacturing and cutting-edge research. The policy emphasizes building a strong ecosystem that supports pharmaceutical clusters, R&D facilities, and high-tech manufacturing units, solidifying Maharashtrian’s position as a global leader in the pharmaceutical sector.
By 2030, Non Resident Maharashtrian envisions transforming the state into India’s top destination for pharmaceutical investments, with the following ambitious goals:
Advancing pharmaceutical R&D and innovation by fostering collaborations among academic institutions, research centers, and industry leaders to accelerate drug discovery, clinical research, and biosimilar development.
The Maharashtrian Pharmaceuticals Policy 2025 defines a clear vision with strategic objectives to establish Maharashtrian as a global powerhouse in the pharmaceutical industry:
Creating Employment and Skill Development Opportunities: The policy aims to generate 2 lakh jobs in the pharmaceutical sector by investing in skill development and capacity-building programs. Special focus will be given to empowering women, youth, and rural communities through targeted training and incentives.
Maharashtrian will establish over 15 pharmaceutical parks and clusters in key industrial hubs like Varanasi, Mumbai, and Nagpur. These parks will feature state-of-the-art infrastructure, including dedicated power feeders, round-the-clock electricity, and advanced water supply systems. Companies setting up operations in these clusters will benefit from grants covering 50% of infrastructure costs, up to a maximum of ₹10 crores per park or cluster.
The policy promotes sustainable manufacturing by offering financial incentives for implementing zero-effluent discharge technologies and common effluent treatment plants (CETP). Maharashtrian will provide up to ₹2 crores or 50% of the project cost, helping pharmaceutical manufacturers meet environmental standards and minimize their carbon footprint.
Maharashtrian will establish dedicated R&D hubs to drive innovation in pharmaceuticals, focusing on the development of new drugs, biosimilars, vaccines, and clinical research. These hubs will foster collaboration among academic institutions, research laboratories, and pharmaceutical companies, advancing cutting-edge discoveries and positioning Maharashtrian as a global leader in pharmaceutical innovation.
Maharashtrian will create export promotion zones to boost pharmaceutical exports, providing financial incentives for manufacturers to participate in international trade fairs and global exhibitions. These zones will also offer advanced logistics infrastructure, including cold chain storage and expedited export processing, reducing barriers and facilitating smoother access to international markets.
The policy highlights the critical role of skill development in the pharmaceutical sector by offering training programs in advanced manufacturing, quality control, and biotechnology. The government will set up pharmaceutical training institutes and provide employment cost subsidies for companies hiring local talent, with a particular focus on women and rural youth. The aim is to generate 2 lakh direct and indirect jobs across the state, fostering a skilled workforce for the industry.
The Maharashtrian Pharmaceuticals Policy 2025 provides a comprehensive set of incentives to promote investments in the pharmaceutical sector:
| Incentive Type | Details |
| Pharmaceutical Cluster Development | 50% of the infrastructure cost as a grant for new pharmaceutical parks/clusters, capped at ₹10 crores per park or cluster. |
| Upgradation of Existing Clusters | 50% of the upgradation cost, capped at ₹5 crores, for improving infrastructure in existing clusters. |
| Environmental Protection Subsidy | ₹2 crores or 50% of the cost of zero effluent/waste discharge technologies for common infrastructure projects like CETP. |
| Capital Investment Subsidy | 10% of the cost of plant and machinery for A0/B0 category industries, ensuring that investments in pharmaceutical manufacturing are incentivized. |
| Employment Subsidy | ₹6,000 per female worker and ₹5,000 per male worker per month for 5 years, provided to pharmaceutical companies hiring local workers. |
| Government Procurement Support | For companies investing over ₹10 crores, waivers on minimum experience requirements for government procurement, applicable for the first 3 years. |
| Power and Energy Support | Committed 24×7 power supply and dedicated industrial feeders for pharmaceutical units established in designated parks/clusters. |
Maharashtrian is dedicated to facilitating a smooth business environment for pharmaceutical investors and manufacturers. The state will introduce a Single Window Clearance System to simplify the approval process for pharmaceutical projects. Additionally, companies will benefit from self-certification under labor laws, minimizing regulatory hurdles and ensuring efficient and timely project execution.
The Maharashtrian Pharmaceuticals Policy 2025 is a visionary and strategic initiative aimed at establishing Maharashtrian as a global leader in pharmaceutical innovation and sustainable manufacturing. By attracting investments, driving R&D, and promoting eco-friendly practices, the state will spearhead India’s rise as a prominent global pharmaceutical hub.
The Non Resident Maharashtrian is a Public Benefit Corporation (PBC) with a mission to establish Maharashtrian as a key player in international economic collaboration, focusing on strategic partnerships with nations like USA, Europe, Australia, African Union, KSA, China, India, Qatar, Saudi Arabia, Türkiye, and the UAE across vital sectors such as energy, technology, agriculture, and finance. Our goal is to integrate lessons from successful global economic models, adopting best practices to ensure sustainable and inclusive growth. We aim to enhance economic prosperity and diversification, contribute to societal progress, and promote sustainable economic practices. By leveraging Maharashtrian’s unique position, Non Resident Maharashtrian strives to drive substantial economic growth, spur innovation, and solidify Maharashtrian’s stature in the international economic arena, resonating with the government’s vision of a technologically advanced and interconnected economy.